Barclays PLC Neoleukin Therapeutics, Inc. Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$0.68 - $0.91 $3,486 - $4,665	-5,127 Reduced 96.92%	163 $0
Q1 2023 May 04, 2023	SELL	$0.5 - $0.72 $223,480 - $321,811	-446,960 Reduced 98.83%	5,290 $4,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.25 $5,259 - $12,863	-5,717 Reduced 1.25%	452,250 $466,000
Q1 2022 May 16, 2022	BUY	$1.72 - $5.23 $787,703 - $2.4 Million	457,967 New	457,967 $861,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.